Excessive inflammation is a hallmark of muscle myopathies, including Duchenne muscular dystrophy (DMD). There is interest in characterising novel genes that regulate inflammation due to their potential to modify disease progression. Gene polymorphisms inSelenoprotein S(Seps1) are associated with elevated proinflammatory cytokines, and in vitro SEPS1 is protective against inflammatory stress. Given that SEPS1 is highly expressed in skeletal muscle, we investigated whether the genetic reduction ofSeps1exacerbated inflammation in themdxmouse. F1 malemdxmice with a heterozygousSeps1deletion (mdx:Seps1−/+) were generated. Themdx:Seps1−/+mice had a 50% reduction in SEPS1 protein expression in hindlimb muscles. In the extensor digitorum longus (EDL) muscles, mRNA expression ofmonocyte chemoattractant protein 1(Mcp-1) (P=0.034), macrophage markerF4/80(P=0.030), andtransforming growth factor-β1(Tgf-β1) (P=0.056) were increased inmdx:Seps1−/+mice. This was associated with a reduction in muscle fibre size; however, ex vivo EDL muscle strength and endurance were unaltered. In dystrophic slow twitch soleus muscles, SEPS1 reduction had no effect on the inflammatory profile nor function. In conclusion, the genetic reduction ofSeps1appears to specifically exacerbate the inflammatory profile of fast-twitch muscle fibres, which are typically more vulnerable to degeneration in dystrophy.